PUBLICATION

Identification of Ly2 members as antimicrobial peptides from zebrafish Danio rerio

Authors
Liu, X., Cao, X., Wang, S., Ji, G., Zhang, S., Li, H.
ID
ZDB-PUB-161217-7
Date
2017
Source
Bioscience Reports   37(1): (Journal)
Registered Authors
Li, Hongyan
Keywords
Antimicrobial peptides, Ly6 gene cluster, zebrafish Danio rerio
MeSH Terms
  • Aeromonas hydrophila/drug effects*
  • Analysis of Variance
  • Animals
  • Antigens, Ly/chemistry
  • Antigens, Ly/genetics
  • Antigens, Ly/isolation & purification
  • Antigens, Ly/pharmacology*
  • Antimicrobial Cationic Peptides/chemistry
  • Antimicrobial Cationic Peptides/genetics
  • Antimicrobial Cationic Peptides/isolation & purification
  • Antimicrobial Cationic Peptides/pharmacology*
  • Bacillus subtilis/drug effects
  • Erythrocytes/drug effects
  • Escherichia coli/drug effects*
  • Humans
  • Lipopolysaccharides/metabolism
  • Mice
  • Protein Refolding
  • RAW 264.7 Cells/drug effects
  • Recombinant Proteins/genetics
  • Recombinant Proteins/isolation & purification
  • Recombinant Proteins/metabolism
  • Recombinant Proteins/pharmacology
  • Staphylococcus aureus/drug effects
  • Zebrafish/genetics
  • Zebrafish/immunology*
  • Zebrafish Proteins/chemistry
  • Zebrafish Proteins/genetics
  • Zebrafish Proteins/isolation & purification
  • Zebrafish Proteins/pharmacology*
PubMed
27980020 Full text @ Biosci. Rep.
Abstract
The emergence of multi-drug resistant (MDR) microbes caused by overuse of antibiotics leads to urgent demands for novel antibiotics exploration. Our recent data showed that Ly2.1-3 (a novel Ly6 gene cluster) were proteins with cationic nature and rich in cysteines content, that are characteristics of antimicrobial peptides (AMPs), and their expression were all significantly up-regulated after challenge with LPS. These strongly suggested that Ly2.1-3 are potential AMPs, but firm evidences are lacking. Here we clearly showed that the recombinant proteins of Ly2.1-3 were capable of killing Gram-negative bacteria A. hydrophila and E. coli , while they had little bactericidal activity against the Gram-positive bacteria S. aureus and B. subtilis We also showed that rLy2.1-3 were able to bind to the Gram-negative bacteria A. hydrophila , E. coli and the microbial signature molecule LPS, but not to the Gram-positive bacteria S. aureus and B. subtilis as well as the microbial signature molecule LTA. Moreover, the Scatchard analysis revealed that rLy2.1-3 could specifically bind to LPS. Finally, we found that Ly2.1-3 were not cytotoxic to mammalian cells. All these together indicate that Ly2.1-3 can function as AMPs.
Genes / Markers
Figures
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Antibodies
Orthology
Engineered Foreign Genes
Mapping